Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04158908 · ClinicalTrials.gov registry record
Giving Information Systematically and Transparently in Lung and GI Cancer Phase 1
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 20
- Enrollment target
NCT04158908 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants.
The verdict
NCT04158908 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
When advanced disease progresses, there comes a time when an oncologists must explain to their patients that they only have months left to live. During these discussions the oncologist attempts to explain to the patient their prognoses and what it means for them going forward. However the investigator's prior studies shown that even when patients only have months left to live, most do not understand that their cancer is incurable and that it is late/end-stage. Dying cancer patients who fully understand their prognosis are able to make more informed decisions and are therefore more likely to engage in advanced care planning, and receive care what in consistent with their values and preferences. They are also in a better position to avoid burdensome, non-beneficial care. The investigator developed Oncolo-GIST in order to help increase the number of patients who fully understand their prognosis and its implications. Oncolo-GIST is an intervention aimed at enhancing clinicians' communication with patients by teaching them to relay information both sensitively and using simple terminology. The Oncolo-GIST training will provide instruction in areas such as how to introduce the topic of prognosis (describe scan results as "worse"), how to phrase the prognosis itself ("likely months, not years"), how to explain expected treatment outcomes (e.g., "not expected to be cured by treatment") and how to describe expected treatments impact on quality of life - that is, whether the anticancer treatment is likely to make them feel overall better or worse. The training materials consist of a manual and a set of videos that act out situations described in the manual. The first phase of this study will consists of two parts: 1. Stakeholder Interviews: The investigator will obtain feedback from relevant stakeholders/key informants on Oncolo-GIST Version 1.0 manual and videos using a version of the Delphi method in which the investigator will interview bereaved family caregivers of ad
Interventions
- BEHAVIORAL Oncolo-GIST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2020-07-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04158908
The ClinicalTrials.gov registry entry for NCT04158908 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oncolo-GIST is the first listed.
NCT04158908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04158908 about?
NCT04158908 is a clinical study titled "Giving Information Systematically and Transparently in Lung and GI Cancer Phase 1". When advanced disease progresses, there comes a time when an oncologists must explain to their patients that they only have months left to live. During these discussions the oncologist attempts to explain to the patient their prognoses and what it means for them going forward. However the investigat...
What is the current status of trial NCT04158908?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2020-01-17. Estimated completion is 2020-07-29.
What interventions are being tested in trial NCT04158908?
The interventions under investigation include: Oncolo-GIST (BEHAVIORAL).
Who is sponsoring clinical trial NCT04158908?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.